<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">101461858</journal-id>
<journal-id journal-id-type="pubmed-jr-id">35583</journal-id>
<journal-id journal-id-type="nlm-ta">Autism Res</journal-id>
<journal-id journal-id-type="iso-abbrev">Autism Res</journal-id>
<journal-title-group>
<journal-title>Autism research : official journal of the International Society for Autism Research</journal-title>
</journal-title-group>
<issn pub-type="ppub">1939-3792</issn>
<issn pub-type="epub">1939-3806</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30977597</article-id>
<article-id pub-id-type="pmc">6499695</article-id>
<article-id pub-id-type="doi">10.1002/aur.2098</article-id>
<article-id pub-id-type="manuscript">NIHMS1021014</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Enhanced social dominance and altered neuronal excitability in the prefrontal cortex of male KCC2b mutant mice</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Anacker</surname>
<given-names>Allison M.J.</given-names>
</name>
<xref ref-type="aff" rid="A1">a</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Moran</surname>
<given-names>Jacqueline T.</given-names>
</name>
<xref ref-type="aff" rid="A2">b</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Santarelli</surname>
<given-names>Sara</given-names>
</name>
<xref ref-type="aff" rid="A2">b</xref>
<xref ref-type="author-notes" rid="FN1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Forsberg</surname>
<given-names>C. Gunnar</given-names>
</name>
<xref ref-type="aff" rid="A3">c</xref>
<xref ref-type="author-notes" rid="FN2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Rogers</surname>
<given-names>Tiffany D.</given-names>
</name>
<xref ref-type="aff" rid="A3">c</xref>
<xref ref-type="author-notes" rid="FN3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Stanwood</surname>
<given-names>Gregg D.</given-names>
</name>
<xref ref-type="aff" rid="A4">d</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hall</surname>
<given-names>Benjamin J.</given-names>
</name>
<xref ref-type="aff" rid="A2">b</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Delpire</surname>
<given-names>Eric</given-names>
</name>
<xref ref-type="aff" rid="A3">c</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Veenstra-VanderWeele</surname>
<given-names>Jeremy</given-names>
</name>
<xref ref-type="aff" rid="A1">a</xref>
<xref ref-type="aff" rid="A3">c</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Saxe</surname>
<given-names>Michael D.</given-names>
</name>
<xref ref-type="aff" rid="A2">b</xref>
<xref ref-type="author-notes" rid="FN4">4</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>a</label>Columbia University and New York State Psychiatric Institute, 1051 Riverside Drive, Mail Unit 78, New York, NY 10025 USA</aff>
<aff id="A2"><label>b</label>Roche Pharmaceutical Research and Early Development, Neuroscience, Ophthalmology and Rare Diseases, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd, Grenzacherstrasse 124, 4070 Basel, Switzerland</aff>
<aff id="A3"><label>c</label>Vanderbilt University School of Medicine, T-4202 MCN, 1161 21st Avenue South, Nashville, TN 37232-2520 USA</aff>
<aff id="A4"><label>d</label>Florida State University, College of Medicine, 1115 West Call St, Tallahassee, FL 32306 USA</aff>
<author-notes>
<fn fn-type="current-aff" id="FN1">
<label>1</label>
<p id="P1">Current affiliation: Boehringer Ingelheim Pharma GmbH &amp; Co. KG, CNS Diseases, Birkendorferstrasse 65, 88400 Biberach and der Riß, Germany</p>
</fn>
<fn fn-type="current-aff" id="FN2">
<label>2</label>
<p id="P2">Current affiliation: Medical University of South Carolina, College of Medicine, Charleston, SC 29425 USA</p>
</fn>
<fn fn-type="current-aff" id="FN3">
<label>3</label>
<p id="P3">Current affiliation: Middle Tennessee State University 355 Jones Hall, 624 Old Main Circle, Murfreesboro, TN 37132 USA</p>
</fn>
<fn fn-type="current-aff" id="FN4">
<label>4</label>
<p id="P4">Current affiliation: Novartis Institutes for BioMedical Research, Neuroscience Department 22 Windsor Street, Cambridge, MA 02139 USA</p>
</fn>
<corresp id="CR1">Address of Correspondence: Jeremy Veenstra-VanderWeele, 1051 Riverside Drive, Mail Unit 78, New York, NY 10025, 646-774-5251, <email>jeremy.veenstra@nyspi.columbia.edu</email>, Michael Saxe, Novartis Institutes for BioMedical Research, Neuroscience Department, 22 Windsor Street, Cambridge, MA 02139 USA617-551-9028, <email>michael.saxe@novartis.com</email></corresp>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>31</day>
<month>3</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="epub">
<day>12</day>
<month>4</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="ppub">
<month>5</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>5</month>
<year>2020</year>
</pub-date>
<volume>12</volume>
<issue>5</issue>
<fpage>732</fpage>
<lpage>743</lpage>
<!--elocation-id from pubmed: 10.1002/aur.2098-->
<abstract id="ABS1">
<p id="P5">The K-Cl cotransporter KCC2 is essential in the development of the “GABA switch” that produces a change in neuronal responses to GABA signaling from excitatory to inhibitory early in brain development, and alterations in this progression have previously been hypothesized to play a causal role in autism spectrum disorder (ASD). We investigated the KCC2b (<italic>Slc12a5</italic>) heterozygous knockout mouse using a battery of rodent behavioral tests relevant to core and co-morbid ASD symptoms. Compared to wild-type littermates, KCC2<sup>+/−</sup> mice were normal in standard measures of locomotor activity, grooming and digging behaviors, and social, vocalization and anxiety-like behaviors. However, KCC2<sup>+/−</sup> mice exhibited increased social dominance behaviors, and increased amplitude of spontaneous postsynaptic currents in the medial prefrontal cortex (PFC) that were previously implicated in governing social hierarchy and dominance behaviors. Treatment of wild-type mouse brain slices with the KCC2 inhibitor VU0240511 increased the amplitude and frequency of excitatory postsynaptic currents, partially recapitulating the phenotype of KCC2<sup>+/−</sup> mice. These findings indicate that the activity of KCC2 plays a role in social dominance, in parallel with effects on PFC signaling, further suggesting that KCC2 function has some relevance to social behavior but without the breadth of impact on autism-like behavior suggested by previous studies. Further testing could assess whether KCC2 alters other circuits, and whether additional factors such as environmental insults may precipitate autism-related behavioral phenotypes.</p>
</abstract>
<abstract abstract-type="summary" id="ABS2">
<title>Lay Summary</title>
<p id="P6">A mouse model of altered chloride transporter expression was used to look for a role in behaviors and brain function relevant to autism. There was an imbalance in signaling in the prefrontal cortex, and increased social dominance behavior, though other autism-related behaviors were not changed. These findings indicate that altered chloride transporter function affects prefrontal cortex function and social dominance without a broader impact on autism-like behaviors.</p>
</abstract>
<kwd-group>
<kwd>Autism</kwd>
<kwd>social</kwd>
<kwd>GABA</kwd>
<kwd>excitatory</kwd>
<kwd>inhibitory</kwd>
<kwd>dominance</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>